Individualized neoadjuvant treatment strategy in adenocarcinoma of the esophago-gastric junction (AEG): Interim report on the MUNICON trial.

被引：0
|
作者：
Lordick, F [1 ]
Weber, WA [1 ]
Stein, HJ [1 ]
Schuhmacher, C [1 ]
Beer, A [1 ]
Hennig, M [1 ]
Ott, K [1 ]
Peschel, C [1 ]
Schwaiger, M [1 ]
Siewert, JR [1 ]
机构：
[1] Tech Univ, Clin Rechts der Isar, Munich, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4060
引用
收藏
页码：328S / 328S
页数：1
相关论文
共 38 条
  • [1] Treatment of esophago-gastric junction adenocarcinoma
    de Manzoni, Giovanni
    Zanoni, Andrea
    Giacopuzzi, Simone
    [J]. ANNALI ITALIANI DI CHIRURGIA, 2012, 83 (03) : 208 - 214
  • [2] Treatment of the esophago-gastric junction adenocarcinoma
    Birla, Rodica
    Iosif, Cristina
    Gindeal, Cristina
    Hoara, P.
    Constantinoiu, S.
    [J]. CHIRURGIA, 2008, 103 (02) : 143 - 153
  • [3] Diagnosis and treatment of gastric cancer and adenocarcinoma of the esophago-gastric junction
    Stocker, G.
    Blaeker, H.
    Denecke, T.
    Gockel, I.
    Hoffmeister, A.
    Kuhnt, Th.
    Hambsch, P.
    Lordick, F.
    [J]. ONKOLOGE, 2021, 27 (10): : 1033 - 1044
  • [4] Diagnosis and treatment of gastric cancer and adenocarcinoma of the esophago-gastric junction
    Stocker, G.
    Blaeker, H.
    Denecke, T.
    Gockel, I
    Hoffmeister, A.
    Kuhnt, Th
    Hambsch, P.
    Lordick, F.
    [J]. GASTROENTEROLOGE, 2022, 17 (02): : 120 - 131
  • [5] Individualized indication for neoadjuvant treatment based on metabolic response assessed by 18-fluorodeoxyglucose positron emission tomography (FDG-PET) in adenocarcinoma of the esophago-gastric junction (AEG).
    Lordick, F
    Ott, K
    Weber, WA
    Stein, HJ
    Becker, K
    Wieder, H
    Roethling, N
    Hennig, M
    Peschel, C
    Schwaiger, M
    Siewert, JR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 318S - 318S
  • [6] Neo-AEGIS (Neoadjuvant Trial in Adenocarcinoma of the Esophagus and Esophago-Gastric Junction International Study): Final primary outcome analysis.
    Reynolds, John V.
    Preston, Shaun R.
    O'Neill, Brian
    Lowery, Maeve Aine
    Baeksgaard, Lene
    Crosby, Thomas
    Cunningham, Moya
    Cuffe, Sinead
    Griffiths, Gareth Owen
    Roy, Rajarshi
    Falk, Stephen
    Hanna, George
    Bartlett, Frederick R.
    Parker, Imelda
    Alvarez-Iglesias, Alberto
    Nilsson, Magnus
    Piessen, Guillaume
    Risum, Signe
    Ravi, Narayanasamy
    McDermott, Raymond S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 295 - 295
  • [7] Management of synchronous adenocarcinoma of the esophago-gastric junction and ampulla of Vater: case report of a surgically challenging condition
    Namita Jayaprakash
    Fardod O'Kelly
    Kheng Tian Lim
    John Vincent Reynolds
    [J]. Patient Safety in Surgery, 3 (1)
  • [8] Management of synchronous adenocarcinoma of the esophago-gastric junction and ampulla of Vater: case report of a surgically challenging condition
    Jayaprakash, Namita
    O'Kelly, Fardod
    Lim, Kheng Tian
    Reynolds, John Vincent
    [J]. PATIENT SAFETY IN SURGERY, 2009, 3
  • [9] A biomarker study of lapatinib in the neoadjuvant treatment of HER2 over expressing esophago-gastric adenocarcinoma (EGA)
    De Silva, Nadeera K.
    Schulz, Laura
    Paterson, Anna
    Nuckcheddy-Grant, Tara
    Qain, Wendi
    Godfrey, Edmund
    Cheow, Heok
    O'Donovon, Maria
    Jobanputra, Minesh
    Hochhauser, Daniel
    Fitzgerald, Rebecca C.
    Ford, Hugo
    [J]. CANCER RESEARCH, 2015, 75
  • [10] Predictive biomarkers for the treatment of resectable esophageal and esophago-gastric junction adenocarcinoma: from hypothesis generation to clinical validation
    Piro, Geny
    Carbone, Carmine
    Santoro, Raffaela
    Tortora, Giampaolo
    Melisi, Davide
    [J]. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2018, 18 (04) : 357 - 370
1234